Biochips Market Forecasts By Industry Drivers, Regions Till 2023

 Market Scenario:

Market Research Future (MRFR) provides an in-depth analysis of regional data with Growth Potential, Opportunities, Drivers, Industry-Specific Challenges for Worldwide Biochips Market.

An expert on premium research reports, Market Research Future has added a report titled "Global Biochips Market 2023" to its offering. The report provides an in-depth analysis by by Type (DNA Chips, Lab-On-A-Chip, and Protein Chips), by Technology (Microarrays, and Microfluidics) By End User (Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostics Centers)-Forecast Till 2023

Global Biochips Market trends held a market value of USD 7,300 million in 2017, according to the MRFR. The market is expected to exhibit a strong 16.6% CAGR over the forecast period from 2018 to 2023, according to the report.

Biochips are intended to function in biological environment, preferably inside living organism. The factors such as increasing technological advancements in biochips is the major driving factor for the market. Moreover, increasing adoption of personalized medicine, as personalised medicine has many applications in cancer genomics. Furthermore, growing applications will boost the biochips market size and growth during forecast period. For instance, biochips can perform thousands of biological reactions operations in few seconds.  

However, high cost of the instruments and stringent regulatory guidelines may restrain the growth of the market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7063

According to national Cancer Institute, in 2018, an estimated 1,735,350 new cases of cancer were diagnosed in the United States and 609,640 people may die from the disease. 
Competitive Landscape:
Perkinelmer, Inc., Fluidigm Corporation, Agilent Technologies, Inc., Abbott Laboratories, Bio-Rad Laboratories Inc., Cepheid Inc., Illumina, Inc., GE Healthcare, Thermo Fisher Scientific, Inc, Roche Diagnostics are some of the prominent players in the global biochips market.

Segmentation:
The Global Biochips Market has been segmented into type, technology, and end user.

By type, the market has been segmented into DNA chips, lab-on-a-chip, protein chips, cell arrays, and tissue arrays. DNA chips is further segmented into gene expression, SNP genotyping, cancer diagnosis & treatment, genomics, drug discovery, agricultural biotechnology, and others. Lab-on-a-chip is further segmented into clinical diagnostics, genomics, IVD (In-Vitro Diagnostic) & POC (Point of care), Proteomics, Drug Discovery, and others. Protein chips is further segmented into proteomics, expression profiling, diagnostics, high-throughput screening, drug discovery, others.

Based on technology, the market has been segmented into microarrays and microfluidics.

The biochips market, by end user, has been segmented into biotechnology and pharmaceutical companies, hospitals and diagnostics centers, academic & research institutes, and others.

Regional Market Summary

Geographically, the Americas is anticipated to dominate the global biochips market owing to the high domestic income, and presence of major market players. Moreover, increasing patient population in US. According to American Cancer Society, the overall estimate of 1,735,350 cases for 2018 equals more than 4,700 new cancer diagnoses each day.

Europe is expected to hold the second largest position in the global biochips market. The market growth in this region is attributed to the presence of strong academic & research base and availability of funding for research in the European countries. For instance, the European Research Council (ERC) provides grants for technological and scientific research conducted within the European Union (EU).

The biochips market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region owing to increasing government focus on biomedical and biotechnology sector and growing number of target population in the region.  

The Middle East & Africa has the lowest biochips market share in global market. Majority of the market of the region is anticipated to be held by the Middle East region owing to the growing government initiatives for the healthcare sector.  

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/biochips-market-7063